Vitamin D May Help Protect Women From Aggressive Breast Cancer
By Michelle Fay Cortez
May 16 (Bloomberg) -- Vitamin D, a byproduct of sunlight and
a supplement in milk, may help protect women from deadly breast
cancer, a study found.
Women with low levels of vitamin D in their blood when they
were diagnosed with cancer were 94 percent more likely to have
the disease spread and 73 percent more likely to die from it a
decade later than those with recommended levels of the vitamin,
researchers said. More than three of every four women had low
levels of the vitamin when they learned they had breast cancer,
according to the study to be presented at the American Society of
Clinical Oncology conference.
Sunshine is the greatest source of vitamin D, produced when
ultraviolet light strikes the skin. Studies have shown vitamin D,
which occurs naturally in few foods, may make several types of
cancer less lethal and protect against breast cancer, the most
common malignancy in women. The latest findings suggest women who
don't get enough of it may be most vulnerable.
``There is growing evidence that there is an optimal range
of vitamin D for a wide range of health outcomes,'' said Pamela
Goodwin, the lead author of the study and professor of medicine
at the University of Toronto. ``We've shown that vitamin D
deficiency is common at breast cancer diagnosis, it's associated
with higher grade tumors and it's associated with an increased
risk of distant recurrence and death.''
Death, Sunscreen
More than 180,000 women will be diagnosed with breast cancer
in the U.S. this year and nearly 41,000 will die, according to
the American Cancer Society. It's the most common cancer in women
and the second-most deadly after lung cancer. Meanwhile, public
health efforts to keep people out of the sun and to use sunscreen
as a way to lower risks of skin cancer have lowered vitamin D
levels, studies show.
The data was reported at an online briefing by ASCO, one of
the nation's largest cancer organizations. The findings will be
presented at ASCO's annual meeting at the end of May.
The study doesn't prove that a lack of vitamin D caused
cancer to become more aggressive, just that a deficiency and
deadly tumors were often linked, Goodwin said. More studies are
needed to confirm the findings and to determine whether giving
vitamin supplements to women with breast cancer will improve
their prognosis, she said at a news conference yesterday.
Too Compelling?
``My concern as it relates to breast cancer risk is women
will avoid other ways to maintain breast health if they feel the
evidence is so compelling that vitamin D reduces risk that they
avoid screening mammograms and all the other general health
things that they should be doing,'' she said.
The study, funded by the Breast Cancer Research Foundation,
included 512 women with an average age of 50 who were followed
for more than a decade after they were diagnosed between 1989 and
1995 at University of Toronto hospitals.
Those with low vitamin D levels also ate few grains and
drank little alcohol. The deficiency was also more common in
younger, overweight women with advanced tumors. Adjusting for
those things didn't change the results, the researchers said.
After a decade, 26 percent of women with a vitamin D
deficiency died from the disease, compared with 15 percent of
those who had adequate levels, the study found. The disease
progressed or metastasized in 31 percent of those with a
deficiency and 17 percent of those with enough of the vitamin.
The findings may lead more women to get tested for vitamin D
deficiency and to correct low levels, said Julie Gralow, chair of
ASCO's cancer communications committee and associate professor at
the University of Washington.
First Study
``This is the first study to really suggest an association
between vitamin D deficiency and the outcome after a diagnosis of
breast cancer, the relapse or the death,'' Gralow said on the
conference call. ``I wouldn't tell someone not to correct their
vitamin D if they knew they had a deficiency,'' she said.
Still, she emphasized that researchers have no idea whether
correcting those levels will improve the women's fate. It may be
that the deficiency leads to higher-risk cancers, and fixing the
problem later won't change the results, she said.
In addition, the study suggested that women whose vitamin D
level is too high may have an increased risk of death, though the
results weren't conclusive.
``We now have a tool to evaluate vitamin D in the blood and
we should begin to use it more'' Goodwin said.
To contact the reporter on this story:
Michelle Fay Cortez in Minneapolis at
mcortez@bloomberg.net
Last Updated: May 16, 2008 00:01 EDT